Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125 - ScienceDirect
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Elecsys CA 125 II
Method comparison of the BR Monitor with the reference method.... | Download Scientific Diagram
Improved early detection of ovarian cancer using longitudinal multimarker models | British Journal of Cancer
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis - ScienceDirect
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis
Serum tumor marker CA 125 for monitoring ovarian cancer during follow-up
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer | PLOS ONE
Multicentre Clinical Evaluation of the COBAS CORE CEA, CA 125 II and PSA Tumor Marker Assays
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
Actual ROC curves for CA 125 assays [pretreatment ovarian cancer (n 46)... | Download Scientific Diagram
Elecsys® CA 125 II
Elecsys® CA 125 II
Frontiers | Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples | British Journal of Cancer
Reagent CA 125 II for Roche Cobas 6000 - Bioprom
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,
